Skip to main content
Clinical Trials/ISRCTN32701387
ISRCTN32701387
Completed
Not Applicable

A comparative study of the efficacy of combination therapy with oral omeprazole and low dose of systemic meglumine antimoniate versus the standard dose of systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis

Skin Diseases and Leishmaniasis Research Center (SDLRC) (Iran)0 sites150 target enrollmentJune 15, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cutaneous leishmaniasis
Sponsor
Skin Diseases and Leishmaniasis Research Center (SDLRC) (Iran)
Enrollment
150
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 15, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Skin Diseases and Leishmaniasis Research Center (SDLRC) (Iran)

Eligibility Criteria

Inclusion Criteria

  • All of the patients had positive smear for leishman body and have not received any topical or systemic therapy for leishmaniasis. The age of patients was between 7\-70 years old.

Exclusion Criteria

  • Patients who were pregnant or lactating and patients with history of cardiac, renal, hepatic diseases or patients with any contraindication for treatment were excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials